- $1.18m
- -$0.43m
- $19.48m
- 51
- 77
- 19
- 47
Annual balance sheet for cbdMD, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 15.1 | 27.4 | 7.72 | 1.8 | 2.45 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.911 | 1.11 | 1.45 | 1.22 | 0.984 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 23.7 | 36.5 | 16 | 8.07 | 6.39 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 10 | 8.18 | 5.3 | 4.07 | 0.54 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 111 | 125 | 40.8 | 16.2 | 10.6 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7.69 | 6.92 | 5.29 | 4.67 | 8.62 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 31.7 | 21.7 | 9.37 | 7.16 | 8.62 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 79.2 | 103 | 31.4 | 9.03 | 1.96 |
Total Liabilities & Shareholders' Equity | 111 | 125 | 40.8 | 16.2 | 10.6 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |